Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex

REFERENCES

• Boulton, S. J., and S. P. Jackson. 1998. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1819–1828.
   PubMed Web of Science ®Google Scholar
• Bressan, D. A., B. K. Baxter, and J. H. J. Petrini. 1999. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:7681–7687.
   PubMedGoogle Scholar
• Bryan, T. M., A. Englezou, L. Dalla-Pozza, M. A. Dunham, and R. R. Reddel. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271–1274.
   PubMed Web of Science ®Google Scholar
• Bryan, T. M., A. Englezou, J. Gupta, S. Bacchetti, and R. R. Reddel. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240–4248.
   PubMed Web of Science ®Google Scholar
• Cerone, M. A., J. A. Londono-Vallejo, and S. Bacchetti. 2001. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10:1945–1952.
   PubMed Web of Science ®Google Scholar
• de Lange, T. 2002. Protection of mammalian telomeres. Oncogene 21:532–540.
   PubMed Web of Science ®Google Scholar
• Dellaire, G., and D. P. Bazett-Jones. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26:963–977.
   PubMed Web of Science ®Google Scholar
• Dunham, M. A., A. A. Neumann, C. L. Fasching, and R. R. Reddel. 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26:447–450.
   PubMed Web of Science ®Google Scholar
• Ford, L. P., Y. Zou, K. Pongracz, S. M. Gryaznov, J. W. Shay, and W. E. Wright. 2001. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276:32198–32203.
   PubMed Web of Science ®Google Scholar
• Greider, C. W., and E. H. Blackburn. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405–413.
   PubMed Web of Science ®Google Scholar
• Grobelny, J. V., A. K. Godwin, and D. Broccoli. 2000. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J. Cell Sci. 113:4577–4585.
   PubMedGoogle Scholar
• Grobelny, J. V., M. Kulp-McEliece, and D. Broccoli. 2001. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet. 10:1953–1961.
   PubMedGoogle Scholar
• Hakin-Smith, V., D. A. Jellinek, D. Levy, T. Carroll, M. Teo, W. R. Timperley, M. J. McKay, R. R. Reddel, and J. A. Royds. 2003. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836–838.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Johnson, F. B., R. A. Marciniak, M. McVey, S. A. Stewart, W. C. Hahn, and L. Guarente. 2001. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20:905–913.
   PubMedGoogle Scholar
• Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015.
   PubMed Web of Science ®Google Scholar
• Kumata, M., M. Shimizu, M. Oshimura, M. Uchida, and T. Tsutsui. 2002. Induction of cellular senescence in a telomerase negative human immortal fibroblast cell line, LCS-AF. 1-3, by human chromosome 6. Int. J. Oncol. 21:851–856.
   PubMedGoogle Scholar
• Le, S., J. K. Moore, J. E. Haber, and C. W. Greider. 1999. RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 152:143–152.
   PubMed Web of Science ®Google Scholar
• Lehming, N., A. Le Saux, J. Schuller, and M. Ptashne. 1998. Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95:7322–7326.
   PubMed Web of Science ®Google Scholar
• Lundblad, V., and E. H. Blackburn. 1993. An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73:347–360.
   PubMed Web of Science ®Google Scholar
• McEachern, M. J., and S. Iyer. 2001. Short telomeres in yeast are highly recombinogenic. Mol. Cell 7:695–704.
   PubMedGoogle Scholar
• Molenaar, C., K. Wiesmeijer, N. P. Verwoerd, S. Khazen, R. Eils, H. J. Tanke, and R. W. Dirks. 2003. Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J. 22:6631–6641.
   PubMed Web of Science ®Google Scholar
• Moller, A., H. Sirma, T. G. Hofmann, H. Staege, E. Gresko, K. S. Ludi, E. Klimczak, W. Droge, H. Will, and M. L. Schmitz. 2003. Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression. Oncogene 22:8731–8737.
   PubMedGoogle Scholar
• Muratani, M., D. Gerlich, S. M. Janicki, M. Gebhard, R. Eils, and D. L. Spector. 2001. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol. 4:106–110.
   Google Scholar
• Murnane, J. P., L. Sabatier, B. A. Marder, and W. F. Morgan. 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13:4953–4962.
   PubMed Web of Science ®Google Scholar
• Nabetani, A., O. Yokoyama, and F. Ishikawa. 2004. Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J. Biol. Chem. 279:25849–25857.
   PubMedGoogle Scholar
• Naka, K., K. Ikeda, and N. Motoyama. 2002. Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem. Biophys. Res. Commun. 299:863–871.
   PubMedGoogle Scholar
• Nakabayashi, K., T. Ogata, M. Fujii, H. Tahara, T. Ide, R. Wadhwa, S. C. Kaul, Y. Mitsui, and D. Ayusawa. 1997. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235:345–353.
   PubMedGoogle Scholar
• Negorev, D., A. M. Ishov, and G. G. Maul. 2001. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci. 114:59–68.
   PubMedGoogle Scholar
• Negorev, D., and G. G. Maul. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20:7234–7242.
   PubMedGoogle Scholar
• Nugent, C. I., G. Bosco, L. O. Ross, S. K. Evans, A. P. Salinger, J. K. Moore, J. E. Haber, and V. Lundblad. 1998. Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8:657–660.
   PubMed Web of Science ®Google Scholar
• Perrem, K., T. M. Bryan, A. Englezou, T. Hackl, E. L. Moy, and R. R. Reddel. 1999. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18:3383–3390.
   PubMedGoogle Scholar
• Perrem, K., L. M. Colgin, A. A. Neumann, T. R. Yeager, and R. R. Reddel. 2001. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21:3862–3875.
   PubMed Web of Science ®Google Scholar
• Rogan, E. M., T. M. Bryan, B. Hukku, K. Maclean, A. C. M. Chang, E. L. Moy, A. Englezou, S. G. Warneford, L. Dalla-Pozza, and R. R. Reddel. 1995. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15:4745–4753.
   PubMed Web of Science ®Google Scholar
• Seeler, J.-S., A. Marchio, D. Sitterlin, C. Transy, and A. Dejean. 1998. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95:7316–7321.
   PubMed Web of Science ®Google Scholar
• Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:787–791.
   PubMed Web of Science ®Google Scholar
• Smogorzewska, A., and T. de Lange. 2004. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73:177–208.
   PubMed Web of Science ®Google Scholar
• Stavropoulos, D. J., P. S. Bradshaw, X. Li, I. Pasic, K. Truong, M. Ikura, M. Ungrin, and M. S. Meyn. 2002. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 11:3135–3144.
   PubMed Web of Science ®Google Scholar
• Sternsdorf, T., K. Jensen, B. Reich, and H. Will. 1999. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274:12555–12566.
   PubMedGoogle Scholar
• Szostecki, C., H. H. Guldner, H. J. Netter, and H. Will. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:4338–4347.
   PubMed Web of Science ®Google Scholar
• Tarsounas, M., P. Munoz, A. Claas, P. G. Smiraldo, D. L. Pittman, M. A. Blasco, and S. C. West. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117:337–347.
   PubMedGoogle Scholar
• Teng, S.-C., J. Chang, B. McCowan, and V. A. Zakian. 2000. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6:947–952.
   PubMed Web of Science ®Google Scholar
• Teng, S.-C., and V. A. Zakian. 1999. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:8083–8093.
   PubMed Web of Science ®Google Scholar
• Toouli, C. D., L. I. Huschtscha, A. A. Neumann, J. R. Noble, L. M. Colgin, B. Hukku, and R. R. Reddel. 2002. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene 21:128–139.
   PubMed Web of Science ®Google Scholar
• Ulaner, G. A., H. Y. Huang, J. Otero, Z. Zhao, L. Ben-Porat, J. M. Satagopan, R. Gorlick, P. Meyers, J. H. Healey, A. G. Huvos, A. R. Hoffman, and M. Ladanyi. 2003. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 63:1759–1763.
   PubMed Web of Science ®Google Scholar
• Usui, T., T. Ohta, H. Oshiumi, J. Tomizawa, H. Ogawa, and T. Ogawa. 1998. Complex formation and functional versatility of Mre11 of budding yeast in recombination. Cell 95:705–716.
   PubMed Web of Science ®Google Scholar
• Wasylyk, C., S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk. 2002. Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol. Cell. Biol. 22:2687–2702.
   PubMedGoogle Scholar
• Wiesmeijer, K., C. Molenaar, I. M. Bekeer, H. J. Tanke, and R. W. Dirks. 2002. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140:180–188.
   PubMedGoogle Scholar
• Wu, G., X. Jiang, W. H. Lee, and P. L. Chen. 2003. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63:2589–2595.
   PubMed Web of Science ®Google Scholar
• Wu, G., W.-H. Lee, and P. L. Chen. 2000. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies bodies during late S/G2 phases in immortalized telomerase-negative cells: Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275:30618–30622.
   PubMedGoogle Scholar
• Yankiwski, V., R. A. Marciniak, L. Guarente, and N. F. Neff. 2000. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97:5214–5219.
   PubMed Web of Science ®Google Scholar
• Yeager, T. R., A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble, and R. R. Reddel. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59:4175–4179.
   PubMed Web of Science ®Google Scholar
• Zhong, S., P. Salomoni, and P. P. Pandolfi. 2000. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:E85–E90.
   PubMed Web of Science ®Google Scholar
• Zhu, X. D., L. Niedernhofer, B. Kuster, M. Mann, J. H. Hoeijmakers, and T. de Lange. 2003. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12:1489–1498.
   PubMed Web of Science ®Google Scholar
• Zhu, X.-D., B. Kuster, M. Mann, J. H. J. Petrini, and T. de Lange. 2000. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25:347–352.
   PubMed Web of Science ®Google Scholar